MDoutlook is a leading disease intelligence company.
We build the success of your organization through better decision-making.


Specializing in oncology, rare and ultra-rare diseases, we answer your business questions using custom market research instruments, our proprietary disease panels, our client side experience and our depth of clinical understanding.


Driven by staff medical experts, our team engages with ThoughtLeaders and the right clinicians to deliver real-world, actionable insights.


Our solutions
MDoutlook provides custom and syndicated market research, ThoughtLeader identification and network mapping, and guaranteed physician engagement.


Click on the above icons to explore how our clients derive value.

What's New at MDoutlook

Redefining engagement with ThoughtLeaders

25 Jun 2019

Identifying the right expert at the right time is often a challenge for many life sciences companies and their agencies. What if there would be…


Conference data presentation impact

24 May 2019

With the deluge of scientific data presentations at a conference, it is very competitive for life science companies to break through the noise and assess…


Rare cancers prominent ahead of the conference season

02 May 2019

Rare cancers feature more prominently at this year’s conference season, and ASCO has named "Progress in Treating Rare Cancers" as their advance of the year.…


What's Trending in Oncology (updated hourly)